MEDEX
Price
$12.55
Change
-$0.08 (-0.63%)
Updated
Sep 11 closing price
Net Assets
7.55B
REBAX
Price
$9.92
Change
-$0.01 (-0.10%)
Updated
Sep 11 closing price
Net Assets
356.62M
Interact to see
Advertisement

MEDEX vs REBAX

MEDEX vs REBAX Comparison Chart in %
View a ticker or compare two or three
VS
MEDEX vs. REBAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDEX is a Hold and REBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MEDEX has more cash in the bank: 7.55B vs. REBAX (357M). MEDEX pays higher dividends than REBAX: MEDEX (5.08) vs REBAX (4.81). MEDEX was incepted earlier than REBAX: MEDEX (18 years) vs REBAX (21 years). MEDEX (1.33) is less costly to investors than REBAX (1.11). MEDEX is a more actively managed with annual turnover of: 69.00 vs. REBAX (42.00). MEDEX has a lower initial minimum investment than REBAX: MEDEX (0) vs REBAX (2000). MEDEX annual gain was more profitable for investors over the last year : 4.94 vs. REBAX (3.95). MEDEX return over 5 years is better than : 9.74 vs. REBAX (8.23).
MEDEXREBAXMEDEX / REBAX
Total Expense Ratio1.321.11119%
Annual Report Gross Expense Ratio1.331.11120%
Fund Existence18 years21 years-
Gain YTD1.6001.112144%
Front LoadN/A5%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.55B357M2,115%
Annual Yield % from dividends5.084.81106%
Returns for 1 year4.943.95125%
Returns for 3 years30.0829.77101%
Returns for 5 years9.748.23118%
Returns for 10 years34.2830.87111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFEIX52.300.45
+0.87%
American Century Large Cap Equity I
HDGSX40.34N/A
N/A
Hartford Dividend and Growth R4
GSTOX23.79N/A
N/A
Goldman Sachs Small Cap Gr Insghts Inv
ATGAX46.75N/A
N/A
Cantor Fitzgerald Equity Opp A
POVDX35.64N/A
N/A
Putnam International Equity R5